Glen Harbor Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $290K | Buy |
22,372
+680
| +3% | +$8.82K | 0.01% | 898 |
|
|
2019
Q2 | $270K | Hold |
21,692
| – | – | 0.01% | 929 |
|
|
2019
Q1 | $315K | Buy |
21,692
+102
| +0.5% | +$1.48K | 0.01% | 849 |
|
|
2018
Q4 | $238K | Buy |
21,590
+6,596
| +44% | +$72.7K | 0.01% | 892 |
|
|
2018
Q3 | $394K | Buy |
14,994
+2,108
| +16% | +$55.4K | 0.01% | 815 |
|
|
2018
Q2 | $264K | Hold |
12,886
| – | – | 0.01% | 882 |
|
|
2018
Q1 | $234K | Buy |
12,886
+68
| +0.5% | +$1.24K | 0.01% | 919 |
|
|
2017
Q4 | $179K | Buy |
12,818
+884
| +7% | +$12.3K | ﹤0.01% | 1014 |
|
|
2017
Q3 | $221K | Buy |
11,934
+3,638
| +44% | +$67.4K | 0.01% | 875 |
|
|
2017
Q2 | $140K | Buy |
8,296
+4,284
| +107% | +$72.3K | ﹤0.01% | 977 |
|
|
2017
Q1 | $54K | Sell |
4,012
-748
| -16% | -$10.1K | ﹤0.01% | 1113 |
|
|
2016
Q4 | $72K | Buy |
+4,760
| New | +$72K | ﹤0.01% | 1008 |
|